chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got a flu shot on 9/4/2017 and could not move her arm the next day. The pain didn't go away after a month so she went to see her doctor. Her doctor said she has frozen shoulder. She had to to physical therapy for 6 months.
A little red rash on the injection site for a few days after 2nd shot; A little red rash on the injection site for a few days after 2nd shot; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE RASH (A little red rash on the injection site for a few days after 2nd shot) and VACCINATION SITE ERYTHEMA (A little red rash on the injection site for a few days after 2nd shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE RASH (A little red rash on the injection site for a few days after 2nd shot). 05-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (A little red rash on the injection site for a few days after 2nd shot). On 07-Mar-2021, VACCINATION SITE RASH (A little red rash on the injection site for a few days after 2nd shot) and VACCINATION SITE ERYTHEMA (A little red rash on the injection site for a few days after 2nd shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-418200, MOD-2021-418208 (Patient Link).
Both Pfizer shots given in same arm (right). Less then a week later have shingles only located on right arm and right hand. The same arm where shots were given.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  The vaccine was administered after 26 days of first puncture.  The Moderna vaccine was used as though it had preservative, just like flu multi-dose vials.   This case was linked to MOD-2021-337435 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Possible NNI.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chills-Medium, Systemic: Diarrhea-Medium, Systemic: Unable to Sleep-Mild
This is a spontaneous report from a contactable physician. This physician reports similar events on 2 different children. This is the first of 2 reports. This physician reports as 29-month-old male received a dose of PREVNAR 13, solution for injection in pre-filled syringe, indication unknown, on 08Sep2010. Relevant medical history, concomitant vaccines and medications, and medication history are unknown. On an unspecified date in 2010, the patient experienced pain and a rash above the injection site. There is no relevant laboratory data. Treatment of the events was unknown. As of 10Nov2010, the injection site rash had resolved after a few days. The outcome of the injection site pain was unknown.
rheumatoid arthritis (which was going out of control according to caller); This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received BNT162B2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE and second dose of BNT162B2 (Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE both for covid-19 immunisation. Medical history included severe histoplasmosis ongoing from 2015, patient added that severe histoplasmosis was diagnosed in 2015 due to Remicade and she was hospitalized for 21 days. Concomitant medication included posaconazole (NOXAFIL) taken for histoplasmosis, start and stop date were not reported. On an unknown date, patient was inquiring about the booster dose and currently taking Inflectra IV for rheumatoid arthritis (which was going out of control according to caller). The outcome of the event was unknown.  Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Severe inflammation throughout my body; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Gu0182) via an unspecified route of administration in the left arm on 18May2021 at 13:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021, the patient experienced severe inflammation throughout the body. The patient reported that she had the vaccine on Tuesday and by Thursday she had severe inflammation throughout her body. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe inflammation throughout my body was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Severe diarrhea started about 10 hours after vaccine. Sore arm, fatigue, muscle aches started about 6 hours after vaccine. 4-5 days after the vaccine I developed axillary lymphadenopathy that is still present after 5 days.
Received vaccine and still has outbreaks; Vaccination failure; This spontaneous report as received from a consumer refers to a patient of unknown age and gender. The patient had shingles when he/she was in 20s. The patient's allergies, drug reactions and concomitant medications were not provided.  On an unknown date the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (shingles vaccine) as prophylaxis. (dose, lot number, expiration date, route of administration and anatomical location were not provided)   The patient had shingles when he/she was in 20s. Ten years ago (unspecified date), patient finally able to get vaccine, but he/she still had occasional outbreaks (herpes zoster) (vaccination failure).  The outcome of herpes zoster was unknown. The reporter did not provide the causality assessment between zoster vaccine live(ZOSTAVAX) (shingles vaccine) and herpes zoster.
Arm hot red & swollen/cellulitis x 4 days; arm swelled from shoulder to mid forearm;
Fever X 2 days, highest 104.6 right (11/13/06). Shaky, tachycardia, fussy, very irritable. Gave Motrin in office; mom treated fever at home with Tylenol.
It started with headache, then started vomiting about 1 1/2 hour later.  Vomited 2 more times and continued to have a headache.  Currently at 12:30 PM on 11/18 only slight headache, and keeping soup down so far.
05/30/2022 I was exposed by my boyfriend from an event he attended. On 6/2/2022  I felt bad all day, kind of fatigued.  About 9:00 that night I had sinus congestion. The next morning, I had fever of 100.6. I had extreme fatigue, no appetite, low grade fever. The congestion was in my head and I had a mild headache. I made an appointment at a clinic, I tested positive and was given Paxlovid. I started it that evening.  I felt better within 5 hours.  My fever went down and was under 100.  I remained fatigued. I finished the Paxlovid the morning of 6/9/2022.  My symptoms were mostly gone except for mucous from my nose and feeling fatigued. I had no fever.   I saw my PCP on 6/9/2022 for my physical.  Every day I feel better. I am taking Sudafed to drain the mucous. My fatigue is gone today, and I feel normal.
Actively has COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Actively has COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Actively has COVID). At the time of the report, COVID-19 (Actively has COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for COVID.         No concomitant medications were reported.  No treatment medications were reported.
pt states she began to feel very dizzy and light headed after vaccine. Pt states she normally feels flushed and dizzy with thought of needles. Pt diaphoretic and crying.
18 YO was administered Engerix-B adult/Inappropriate Dose Administered; 18 YO was administered Engerix-B adult/Inappropriate Dose Administered; This case was reported by a nurse via call center representative and described the occurrence of accidental overdose in a 18-year-old female patient who received HBV (Engerix B adult) (batch number 434SR, expiry date 11th August 2023) for prophylaxis.   On 1st February 2022, the patient received the 1st dose of Engerix B adult. On 1st February 2022, unknown after receiving Engerix B adult, the patient experienced accidental overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the accidental overdose and inappropriate age at vaccine administration were unknown.  Additional details were provided as follows: Nurse reported that 18 year of age patient was administered the Engerix-B adult vaccine on right deltoid inadvertently, which led to accidental overdose and inappropriate age at vaccine administration. The reporter consented to follow up.
Tiredness , body aches, bad neck ache,fever,chills and large knot at injection site
Information has been received from a physician concerning a 13 year old female patient with attention deficit disorder, bipolar disorder and esophageal reflux disease who on 09-MAR-2011, was vaccinated with the first dose of GARDASIL (Lot # 666595/0096Z and expiration on 08-AUG-2012). The physician stated that weekend phone service had a message from the patient complaining of fever and difficulty walking after her first dose of GARDASIL on 09-MAR-2011. The physician recommended the patient visit the emergency room but she never went to the hospital. At the time of reporting the patient's outcome patient was unknown. Additional information has been requested.
Heart palpitations, profuse sweating, profuse vomiting, profuse diarrhea, chills, hot and cold flashes, nausea, weakness
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 15-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in left arm and as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Weather induced asthma" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing). Known allergies reported as o. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 30Aug2023 to 04Sep2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 has been requested and will be submitted if and when received.
grandmother called stated pt leg was red & swollen; pt crying alot; mom stated pt's aunt had very similar reaction; pt was running fever; was given APAP & DPH;
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Vomiting-Medium
blood pumping to my head and became very hot; face turned red and was hot to the touch; blood pumping to my head and became very hot; face turned red and was hot to the touch; blood pumping to my head and became very hot; face turned red and was hot to the touch; facial muscles became weak on both; difficult to make facial expressions; my mouth began to tremble; chills; facial muscles became weak on both; difficult to make facial expressions; This is a spontaneous report from contactable consumers. An 70-year-old female non-pregnant patient received her first dose bnt162b2 (BNT162B2; Solution for injection; lot number: EL9283) via an unspecified route of administration at Left arm on 28Jan2021 12:30 at single dose for COVID-19 immunisation at Clinic. Medical history included high blood pressure, high cholesterol. Concomitant medication included rosuvastatin calcium (CRESTOR), amlodipine, calcium carbonate simethicone. There was no other vaccines in four weeks. The patient previously took iodine had contrast, procaine hydrochloride (NOVOCAIN) had drug allergy, omeprazole (PRILOSEC) and had drug allergy, olmesartan medoxomil (BENICAR) had drug allergy. Five minutes after the injection 28Jan2021 12:35, patient felt blood pumping to her head and became very hot. Her face turned red and was hot to the touch. Then, facial muscles became weak on both sides and made it difficult to make facial expressions. Lastly, her mouth began to tremble and had chills. Symptoms subsided about 30 minutes after the injection. she worried about getting the second injection. The patient received treatment with Liquids/electrolytes. The events result in doctor or other healthcare professional office/clinic visit. The outcome of the events was recovered in 2021.
the day after vaccine,  2-22-2021, shills, nausea, extreme fatigue, headache, and muscle pain.  2-23-2021, only extreme fatigue  and some muscle pain
Redness on calves part of leg, rash like blisters. Time injection to currently. Burns and itches
pt recvd vax 21JUN94 mom states noticed rash on rt arm 22JUN94 spreading to trunk, then other extremities; denies any fever, difficulty breathing or swallowing; mild urticarial type rash;
Pt. noticed soreness that radiated up her arm to her clavicle and neck area. approx. 1600 noted nausea and warmness that resolved within a half hour. Injection site was wnl, and not tender. Pt denies need for outside treatment.
This spontaneous report was received from a nurse via a company representative referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, route, site of administration, lot # and expiration date were not provided) for prophylaxis. On an unknown date, the patient experienced an outbreak of shingles on the thorax area a week after receiving ZOSTAVAX. The outcome of shingles was reported as recovered/resolved. Causality assessment was not provided. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM  2/9/2022,  6/10/2022,  9/7/2022,  9/11/2022,  9/23/2022,  11/7/2022 --RECURRENCE OF SAME SYMPTOMS
Arm was little bit sore but now its kind of little bit swollen and it's very sensitive to touch; Arm was little bit sore but now its kind of little bit swollen and it's very sensitive to touch; Arm was little bit sore but now its kind of little bit swollen and it's very sensitive to touch; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 09Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), PERIPHERAL SWELLING (non-serious), HYPERAESTHESIA (non-serious), outcome "unknown" and all described as "Arm was little bit sore but now its kind of little bit swollen and it's very sensitive to touch".  Additional information: System Reference: No transfer required. No the report is not related to a study or programme. Yes, the patient also the reporter. Reason for no lot number: of Covid-19 Vaccine: Complainant hung up abruptly/transfer incomplete. Expiry Date of Covid-19 Vaccine: Unknown. Consumer stated, pt received 4th Pfizer vaccination on Saturday and pt was fine, pt arm was little bit sore but now it was kind of little bit swollen and it was very sensitive to touch. Should pt just take some Tylenol or Advil or was there something pt should take to try to help with the reaction. Pt took the 4th shot for the Pfizer COVID vaccine (Clarified as Pfizer Covid-19 vaccine). Consumer was informed about the role of Pfizer Drug Safety.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
SENSATION OF RINGING IN BOTH EARS (TINNITUS); NASAL CONGESTION; This spontaneous report received from a patient concerned a 22 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: seasonal allergies, and other pre-existing medical conditions included: Patient had no illness at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095 expiry: 01-MAR-2022) dose was not reported, administered on 30-JUN-2021 for prophylactic vaccination. Age at time of vaccination 22 years old. No concomitant medications were reported. On 01-JUL-2021, the patient experienced nasal congestion. On 15-JUL-2021, the patient experienced sensation of ringing in both ears (tinnitus). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nasal congestion on 08-JUL-2021, and had not recovered from sensation of ringing in both ears (tinnitus). This report was non-serious.
Elevated temperature 103 + F Severe body (muscle & joint) pain Symptoms started approx 12 hrs after injection and subsided approx 40 hrs after injection.  Partially responded to treatmen with acetaminophen.
Loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 11:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication received within two weeks of vaccination was not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, the patient experienced loss of taste. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event loss of taste was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Ringing in left ear; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 05Apr2021 at 14:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 05Apr2021 at 15:00, the patient experienced ringing in left ear. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event ringing in left ear was not recovered.   No follow-up attempts are needed. No further information is expected.
pt recvd vax & 18 days later exp fever (ranging from 101 to 104), aches, chills, malaise, & dec appetite;
Patient received Pfizer vaccinations on 12/29/20 and 1/19/21. She woke up on 1/20 with hot flashes, fatigue and chills. Later in the day she developed a headache. This morning  (1/22) as she was walking to her car to go to work she developed dyspnea and palpitations.  She had a portable pulse ox and noted HR was 125 and PO2 97%.  She went to ED, COVID neg, d-dimer positive, CT chest negative for PE. Potassium was low. Patient was discharged home.
PNEUMOVAX given at approx 10:15a.m.  Pt stated at 12:00 noon - rash all over body (welts).  At 1:30p.m. pt presented to office c/o throat swelling, rash and extremities swelling.  Pt advised to go to ER.  Pt would not leave office.  Dr. notified.  Pt had taken BENADRYL.  Dr. said monitor pt.
Severe body aches, fever, loss of energy, loss of appetite. Symptoms persisted for 24 hours.